COMMUNIQUÉS West-GlobeNewswire

Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
20/10/2025
Using AI and a smartphone camera, Noom makes personalized health screening and motivational tools accessible to all for free Noom’s free Face Scan feature PRINCETON, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Noom , the [...]
ThrIVe Health Announces Patient Education Seminar Featuring Leading Thyroid Eye Disease Specialist Dr. Raymond Douglas
20/10/2025
World-Renowned Oculoplastic Surgeon Dr. Raymond Douglas and Board-Certified Endocrinologist Dr. Gladys E. Palomeno to Address Patients, Caregivers, and Healthcare Professionals Beverly Hills, CA, Oct. 20, 2025 (GLOBE [...]
IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor
20/10/2025
PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appointment of Ann Marie Dunne [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
20/10/2025
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy in 16 patients with metastatic uveal melanoma in the ongoing Phase 1b trial continues to show strong clinical benefit with more mature [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
20/10/2025
Taipei, Taiwan, Oct. 20, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Solana Company Executive Chairman’s Message: October 20th, 2025
20/10/2025
NEWTOWN, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Today, Solana Company (NASDAQ: HSDT) released the following letter from the Executive Chairman: We are excited to enter the next phase of our lifecycle with a strong [...]
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverages Across New England Through Atlantic Importing Alliance
20/10/2025
WESTBROOK, Maine, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with Atlantic Importing Company [...]
MBX Biosciences to Participate in November Investor Conferences
20/10/2025
CARMEL, Ind., Oct. 20, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
20/10/2025
Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS) Prolonged tumor control with increasing doses of BA3182; confirmed partial response (cPR) at 0.6 mg in a [...]
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
20/10/2025
HORSHAM, Penn., Oct. 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
20/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary [...]
Oncotelic to Present at the LD Micro Main Event XIX
20/10/2025
AGOURA HILLS, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat cancer [...]
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
20/10/2025
NORCROSS, Ga., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will [...]
AIM ImmunoTech to Attend the 2025 Maxim Growth Summit
20/10/2025
OCALA, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced it will participate at the 2025 Maxim Growth Summit , taking place October 22-23, 2025 in [...]
Eleos to Launch Polaris AI Advanced, Purpose-Built Foundational AI Model for Post-Acute Care, built with Google Cloud Technology
20/10/2025
Polaris AI leverages Google Cloud’s Gemini family of multimodal models and Eleos’ secure and clinically validated infrastructure to reduce documentation burden, strengthen compliance and help providers focus on care. [...]
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025
20/10/2025
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that it will present initial [...]

Pages